by: Mike Huckman posted on: July 24, 2008 | about stocks: PFE ) earnings conference call yesterday morning, Chairman and CEO Jeff Kindler kicked things off by calling this a "time of great uncertainty in the world economy and capital markets and significant challenges in our industry." As a Pfizer PR person pointed out in an email following my earnings story on "Squawk on the Street" yesterday morning, worldwide Viagra sales in the second quarter were up 21 percent versus the same period last year, U.S. Viagra revenue was up a whopping 41 percent and international sales of the little blue pill rose nine percent. But I like to look behind the numbers, oftentimes much to the consternation of the above-mentioned PR person and his/her colleagues at PFE and at other drug companies. I think I found an interesting trend, if you can...
[read full story]
Your Web Site
